Summit Global Investments’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$621K Sell
4,737
-2,597
-35% -$332K 0.03% 322
2026
Q2
$1.39M Sell
7,334
-664
-8% -$98.5K 0.08% 141
2026
Q1
$744K Hold
7,998
– – 0.04% 256
2025
Q4
$643K Sell
7,998
-87
-1% -$7.28K 0.04% 267
2025
Q3
$789K Buy
+8,085
New +$651K 0.05% 233
2024
Q4
– Sell
-7,297
Closed -$765K – 521
2024
Q3
$765K Sell
7,297
-722
-9% -$84.4K 0.05% 283
2024
Q2
$1.14M Sell
8,019
-953
-11% -$110K 0.08% 217
2024
Q1
$1M Buy
+8,972
New +$1.07M 0.07% 213
2023
Q4
– Sell
-3,441
Closed -$561K – 503
2023
Q3
$561K Sell
3,441
-1,659
-33% -$292K 0.04% 321
2023
Q2
$935K Buy
5,100
+1,300
+34% +$187K 0.06% 240
2023
Q1
$506K Buy
+3,800
New +$446K 0.04% 345

Other funds holding ACLS

Summit Global Investments's ACLS Position: Q3 2026 in Review

Summit Global Investments reduced its Axcelis (ACLS) stake by 35% in Q3 2026, selling an estimated $332K and leaving 4,737 shares worth $621K. The position accounts for 0.03% of the portfolio, ranked #322.

Summit Global Investments first reported a position in ACLS in Q1 2023 and has held it in 11 quarters since. The position peaked at $1.39M in Q2 2026. 132 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Summit Global Investments held 4,737 shares of Axcelis worth $621K as of Q3 2026.
  • Summit Global Investments sold 2,597 Axcelis shares in Q3 2026, an estimated $332K.
  • Axcelis made up 0.03% of Summit Global Investments's portfolio in Q3 2026, its #322 holding.
  • Summit Global Investments first reported a position in Axcelis in Q1 2023 and has held it in 11 quarters since.
  • Summit Global Investments's Axcelis position peaked at $1.39M in Q2 2026.
  • 132 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Summit Global Investments's 13F filing for Q3 2026, filed 28 Oct 2026.